Genichiro Ishii

40PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Apr 15, 2026
Hepatic-Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi-Omics Analysis of Tumors With Lymphovascular Invasion.

Shugo Yajima, Yuichiro Tsukada, Riu Yamashita

|Apr 09, 2026
Transgelin Expression in Activated Cancer-Associated Fibroblasts Regulates Stromal Contractility and Promotes Colon Cancer Progression.

Ryuji Okamoto, Tetsuro Hiroi, Yuka Nakamura

|Apr 03, 2026
Significance of Preoperative Imaging-Detected Extranodal Extension in Pathological Extranodal Extension-Positive Head and Neck Squamous Cell Carcinoma Treated With Postoperative Chemoradiotherapy.

Yuta Hoshi, Hirofumi Kuno, Shingo Sakashita

|Dec 16, 2025
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness.

Shunta Tsuchida, Tetsuro Taki, Kotaro Nomura

Pageof 7

Frequent Collaborators

13 joint publications

Motohiro Kojima

12 joint publications

Naoya Sakamoto

7 joint publications

Shingo Sakashita

5 joint publications

Hiroyoshi Nishikawa